Latest Oritavancin Stories
However, New Agents Seeking To Penetrate the OPAT Market Must Gain Favorable Positioning in the Hospital Setting, According to Findings from Decision Resources Group BURLINGTON, Mass., July
LONDON, June 12, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Two separate studies published this week in the New England Journal of Medicine are paving the way for more effective treatments in deadly methicillin-resistant Staphylococcus aureus (MRSA) infections.
WOBURN, Mass., May 16, 2014 /PRNewswire/ -- AdvanDx, Inc., a leading provider of molecular diagnostic tests for the rapid identification of bloodstream infections, announced today that data from thirteen
IRVINE, Calif., April 8, 2014 /PRNewswire/ -- Sideromics LLC, a pharmaceutical company specializing in the development of novel antimicrobial compounds, announced today that the company has successfully
Lipoglycopeptides Dalvance and Oritavancin Will Find Favorable Uptake as Convenient Outpatient Anti-MRSA Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., April
MarketResearchReports.Biz announces addition of new report “Skin And Skin Structure Infections (SSSI) Caused By Bacteria 2013” to its database.
- To fire mitraille at.